Katrina A Lambert1, Luke A Prendergast2, Shyamali C Dharmage3, Mimi Tang4,5, Molly O'Sullivan5, Thomas Tran6, Julian Druce6, Philip Bardin7, Michael J Abramson8, Bircan Erbas1. 1. a School of Psychology and Public Health , La Trobe University , Victoria , Melbourne , Australia. 2. b Department of Mathematics and Statistics , La Trobe University , Victoria , Melbourne , Australia. 3. c Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health , The University of Melbourne , Victoria , Melbourne , Australia. 4. d Department of Paediatrics , The University of Melbourne , Victoria , Melbourne , Australia. 5. e Murdoch Children's Research Institute , The Royal Children's Hospital , Victoria , Melbourne , Australia. 6. f Victorian Infectious Diseases Reference Laboratory, The Doherty Institute , Victoria , Melbourne , Australia. 7. g Faculty of Medicine, Nursing and Health Sciences , Monash University and Hospital , Victoria , Melbourne , Australia. 8. h School of Public Health and Preventive Medicine , Monash University , Victoria , Melbourne , Australia.
Abstract
OBJECTIVE: It is recognized that human rhinovirus (HRV) infection is an important factor in asthma exacerbations requiring hospitalization in children. However, previous studies have disagreed on the differential impact of various HRV species. We sought to assess the impact of HRV species on the severity of asthma exacerbations in children and adolescents. We also examined whether the effect of HRV species on severity was modified by age and gender. METHODS: Virus strain was determined for 113 children with HRV detectable at the time of admission for asthma exacerbation. Patient characteristics were collected on admission and exacerbation severity was scored using several validated scales. RESULTS: HRV species by itself was not associated with moderate/severe vs. mild exacerbations. Boys with HRV-C infections were more likely (OR: 3.7, 95% CI: 1.2-13.4) to have a moderate/severe exacerbation than girls with HRV-C (p = 0.04 for interaction term). Higher odds were observed in younger boys (3 years old: OR: 9.1, 95% CI: 1.8-47.1 vs 5 years old: OR: 3.3, 95% CI: 0.9-11.8 vs 7 years old: OR: 1.2, 95% CI: 0.2-6.6). In contrast, children with HRV-C infection and sensitized to pollen during the pollen season were less likely to have moderate/severe exacerbations (p = 0.01 for the interaction term). CONCLUSION: Acute asthma exacerbations are more likely to be moderate/severe in boys under 5 years of age who had HRV-C infection on admission. The opposite was found in children with sensitization to pollen during pollen season.
OBJECTIVE: It is recognized that human rhinovirus (HRV) infection is an important factor in asthma exacerbations requiring hospitalization in children. However, previous studies have disagreed on the differential impact of various HRV species. We sought to assess the impact of HRV species on the severity of asthma exacerbations in children and adolescents. We also examined whether the effect of HRV species on severity was modified by age and gender. METHODS: Virus strain was determined for 113 children with HRV detectable at the time of admission for asthma exacerbation. Patient characteristics were collected on admission and exacerbation severity was scored using several validated scales. RESULTS:HRV species by itself was not associated with moderate/severe vs. mild exacerbations. Boys with HRV-C infections were more likely (OR: 3.7, 95% CI: 1.2-13.4) to have a moderate/severe exacerbation than girls with HRV-C (p = 0.04 for interaction term). Higher odds were observed in younger boys (3 years old: OR: 9.1, 95% CI: 1.8-47.1 vs 5 years old: OR: 3.3, 95% CI: 0.9-11.8 vs 7 years old: OR: 1.2, 95% CI: 0.2-6.6). In contrast, children with HRV-C infection and sensitized to pollen during the pollen season were less likely to have moderate/severe exacerbations (p = 0.01 for the interaction term). CONCLUSION: Acute asthma exacerbations are more likely to be moderate/severe in boys under 5 years of age who had HRV-C infection on admission. The opposite was found in children with sensitization to pollen during pollen season.
Authors: Fanny Wai-San Ko; Paul Kay-Sheung Chan; Renee W Y Chan; Ka-Pang Chan; April Ip; Angela Kwok; Jenny Chun-Li Ngai; So-Shan Ng; Chan Tat On; David Shu-Cheong Hui Journal: Respir Res Date: 2019-09-13
Authors: M M van der Zalm; E Walters; M Claassen; M Palmer; J A Seddon; A M Demers; M L Shaw; E D McCollum; G U van Zyl; A C Hesseling Journal: BMC Infect Dis Date: 2020-12-04 Impact factor: 3.090
Authors: Erwan Sallard; Katarzyna Niespodziana; Maja Bajic; Thomas Schlederer; Peter Errhalt; Ann-Kathrin Behrendt; Stefan Wirth; Almut Meyer-Bahlburg; Anja Ehrhardt; Rudolf Valenta; Malik Aydin Journal: Viruses Date: 2022-08-24 Impact factor: 5.818
Authors: Toby C Lewis; Ediri E Metitiri; Graciela B Mentz; Xiaodan Ren; Adam M Goldsmith; Breanna N Eder; Kyra E Wicklund; Megan P Walsh; Adam T Comstock; Jeannette M Ricci; Sean R Brennan; Ginger L Washington; Kendall B Owens; Bhramar Mukherjee; Thomas G Robins; Stuart A Batterman; Marc B Hershenson Journal: Ann Allergy Asthma Immunol Date: 2018-10-29 Impact factor: 6.347
Authors: Satria P Sajuthi; Peter DeFord; Yingchun Li; Nathan D Jackson; Michael T Montgomery; Jamie L Everman; Cydney L Rios; Elmar Pruesse; James D Nolin; Elizabeth G Plender; Michael E Wechsler; Angel C Y Mak; Celeste Eng; Sandra Salazar; Vivian Medina; Eric M Wohlford; Scott Huntsman; Deborah A Nickerson; Soren Germer; Michael C Zody; Gonçalo Abecasis; Hyun Min Kang; Kenneth M Rice; Rajesh Kumar; Sam Oh; Jose Rodriguez-Santana; Esteban G Burchard; Max A Seibold Journal: Nat Commun Date: 2020-10-12 Impact factor: 14.919